Figure 3From: Hypermethylated 14-3-3-σ and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis 14-3-3-σ values measured in serum of patients with breast cancer metastatic disease before the first C(0) and successive C(1...5) chemotherapy cycles, in patients with "continuous decline" biomarker pattern.Back to article page